Literature DB >> 1663224

GABA-mediated inhibition in rostral ventromedial medulla: role in nociceptive modulation in the lightly anesthetized rat.

Mary M Heinricher1, Hilary J Kaplan.   

Abstract

Local microinjection of GABAA receptor agonists and antagonists was used to characterize the role of GABA-mediated inhibitory processes in the nociceptive modulatory functions of the rostral ventromedial medulla (RVM) in the lightly anesthetized rat. Microinjection of selective GABAA receptor antagonists bicuculline methiodide and SR95531 produced a significant increase in tail-flick (TF) latency. This antinociception was dose related, showed recovery and was attenuated by prior injection of the GABAA receptor agonist THIP at the same site. Microinjection of saline or the glycine receptor antagonist strychnine did not significantly affect TF latency. In contrast, administration of GABAA receptor agonists THIP and muscimol resulted in a significant decrease in TF latency. Microinjections at sites surrounding the RVM did not significantly affect TF latency. These results demonstrate that a GABA-mediated process within the RVM is crucial in permitting execution of the TF and, presumably, other spinal nociceptive reflexes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1663224     DOI: 10.1016/0304-3959(91)90017-R

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  25 in total

1.  Role of 5-HT(1) receptor subtypes in the modulation of pain and synaptic transmission in rat spinal superficial dorsal horn.

Authors:  Hyo-Jin Jeong; Vanessa A Mitchell; Christopher W Vaughan
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  A novel, non-invasive method of respiratory monitoring for use with stereotactic procedures.

Authors:  Daniel R Cleary; Ryan S Phillips; Michael Wallisch; Mary M Heinricher
Journal:  J Neurosci Methods       Date:  2012-07-04       Impact factor: 2.390

3.  Modulation of spinal GABAergic analgesia by inhibition of chloride extrusion capacity in mice.

Authors:  Marina N Asiedu; Galo Mejia; Michael K Ossipov; T Phillip Malan; Kai Kaila; Theodore J Price
Journal:  J Pain       Date:  2012-04-25       Impact factor: 5.820

4.  Effects of GABAA receptors in nucleus cuneiformis on the cannabinoid antinociception using the formalin test.

Authors:  Junjie Chen; Parisa Hasanein; Alireza Komaki; Siamak Yari
Journal:  Psychopharmacology (Berl)       Date:  2021-03-13       Impact factor: 4.530

5.  The modulatory effects of rostral ventromedial medulla on air-puff evoked microarousals in rats.

Authors:  H Foo; Katherine Crabtree; Peggy Mason
Journal:  Behav Brain Res       Date:  2010-07-17       Impact factor: 3.332

6.  Rostral ventromedial medulla μ, but not κ, opioid receptors are involved in electroacupuncture anti-hyperalgesia in an inflammatory pain rat model.

Authors:  Yu Zhang; Aihui Li; Lixing Lao; Jiajia Xin; Ke Ren; Brian M Berman; Rui-Xin Zhang
Journal:  Brain Res       Date:  2011-04-28       Impact factor: 3.252

7.  Entanglement between thermoregulation and nociception in the rat: the case of morphine.

Authors:  Nabil El Bitar; Bernard Pollin; Elias Karroum; Ivanne Pincedé; Daniel Le Bars
Journal:  J Neurophysiol       Date:  2016-09-07       Impact factor: 2.714

8.  CC12, a P450/epoxygenase inhibitor, acts in the rat rostral, ventromedial medulla to attenuate morphine antinociception.

Authors:  Jennie L Conroy; Julia W Nalwalk; James G Phillips; Lindsay B Hough
Journal:  Brain Res       Date:  2013-01-05       Impact factor: 3.252

Review 9.  Descending control of nociception: Specificity, recruitment and plasticity.

Authors:  M M Heinricher; I Tavares; J L Leith; B M Lumb
Journal:  Brain Res Rev       Date:  2008-12-25

10.  Brainstem control of cerebral blood flow and application to acute vasospasm following experimental subarachnoid hemorrhage.

Authors:  J S Cetas; D R Lee; N J Alkayed; R Wang; J J Iliff; M M Heinricher
Journal:  Neuroscience       Date:  2009-06-17       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.